Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
33
Number of overlapping holdings
82.5%
% of XPH's 40 holdings also in IHE
97.1%
% of IHE's 34 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 4.8% | 4.8% | 4.8% |
|
ELI LILLY & CO | 4.8% | 23.4% | 4.8% |
|
PFIZER INC | 4.6% | 4.6% | 4.6% |
|
VIATRIS, INC. | 4.5% | 4.5% | 4.5% |
|
ROYALTY PHARMA PLC CLASS A | 4.5% | 4.6% | 4.5% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to IHE
|
AXSOME THERAPEUTICS, INC. | 3.4% |
 |
PERRIGO CO | 3.0% |
|
CORCEPT THERAPEUTICS INC | 2.7% |
|
ORGANON & CO. | 2.6% |
|
PSIVIDA CORP | 2.2% |
|
INTRA-CELLULAR THERAPIES INC | 2.2% |
|
ARVINAS, INC. | 1.7% |
|
JAZZ PHARMACEUTICALS PLC | 1.6% |
|
CASSAVA SCIENCES, INC. | 1.6% |
|
AMPHASTAR PHARMACEUTICALS INC | 1.4% |
XPH Underweight Relative to IHE
|
ELI LILLY & CO | -18.6% |
|
JOHNSON & JOHNSON | -17.8% |
|
EDGEWISE THERAPEUTICS, INC. | -0.4% |
|
ROYALTY PHARMA PLC CLASS A | -0.1% |
|
PRESTIGE BRANDS HOLDINGS INC | 0.0% |
|
BRISTOL-MYERS SQUIBB CO | 0.0% |
|
VIATRIS, INC. | 0.0% |
|
PFIZER INC | 0.0% |
|
MERCK & CO. INC. | 0.0% |
|
ZOETIS INC | 0.0% |